Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM-a prospective, randomized, single-centre, open-label study
Clinical Microbiology and Infection (2022) - Comments
pubmed: 35259529  doi: 10.1016/j.cmi.2022.02.027  issn: 1198-743x  issn: 1469-0691 

Niklas Broman, Thijs Feuth, Tytti Vuorinen, Mika Valtonen, Ulla Hohenthal, Eliisa Löyttyniemi, Tiina Hirvioja, Päivi Jalava-Karvinen, Harri Marttila, Marika Nordberg, Jarmo Oksi